Avicanna to present at the Q1 Virtual Investor Summit
Avicanna (AVCNF) announces CEO Aras Azadian's participation in the upcoming Q1 Virtual Investor Summit from March 23-25, 2021. Azadian's presentation is scheduled for March 24 at 2:00 PM ET. The summit is designed to connect smallcap and microcap companies with over 300 institutional and retail investors, featuring 100 participating companies. Interested investors can register for free at www.investorsummitgroup.com.
- None.
- None.
TORONTO, March 11, 2021 (GLOBE NEWSWIRE) -- via InvestorWire- Avicanna (AVCNF) today announced that Aras Azadian, CEO, will be attending the Q1 Virtual Investor Summit.
| Event | Q1 Investor Summit | ||
| Date | March 23-25th, 2021 | ||
| Presentation | March 24th @ 2:00PM ET | ||
| Location | https://zoom.us/webinar/register/WN_gqM8YnegRIqpec0qI9JuVw |
About The Investor Summit
The Investor Summit (formerly MicroCap Conference) is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors. The Q1 Investor Summit will take place virtually, featuring 100 companies and over 300 institutional and retail investors.
To request complimentary investor registration: please visit our website at www.investorsummitgroup.com
Contact:
Brittney Blocker at brittney@investorsummitgroup.com
ABOUT Avicanna
Avicanna is a diversified and vertically integrated Canadian biopharmaceutical company focused on the research, development, and commercialization of plant-derived cannabinoid-based products for the global consumer, medical, and pharmaceutical market segments.
Wire Service Contact:
InvestorWire (IW)
Los Angeles, California
212.418.1217 Office
Editor@InvestorWire.com
FAQ
When is the Q1 Investor Summit for Avicanna (AVCNF)?
What time will Avicanna's CEO present at the Investor Summit?
How can I register for the Q1 Investor Summit?
What is the focus of the Q1 Investor Summit?
How many companies will participate in the Investor Summit?
